hemorrhage ranging broadly from 0% to 42%. 1,6-11,13-15, 17-26,28-31,33,34 The majority of these hemorrhages appear to be small and not clinically significant.
While the risks associated with EVD placement have been studied extensively, there is little information regarding risks with EVD removal (Table 1 ). The incidence of hemorrhage associated with removal of an EVD has been documented in a few articles but has not been studied rigorously. 8, 18, 28 The risk factors for EVD removal seem similar intuitively to those for EVD placement, but removal of an EVD is typically viewed as a trivial procedure. Given the relative scarcity of data on the subject, we investigated the incidence of hemorrhage and associated risk factors with both EVD placement and removal.
methods patient selection
This study was completed in accordance with a research protocol approved by the institutional review board at the University of Minnesota Medical Center. It followed the Health Insurance Portability and Accountability Act standards for privacy of personal health information. A departmental database was searched for any patient in whom an EVD was placed from March 2008 to June 2014. All medical records and brain images (MRI and helical CT) were reviewed for parameters including admission date and time; admission diagnosis; medical comorbidities; indication for ventriculostomy; coagulation parameters and platelet counts at admission, prior to EVD placement and prior to EVD removal; blood product transfusions administered prior to the procedure; location of EVD; number of passes needed for successful placement; time of postprocedural imaging; new hemorrhage on postprocedural imaging; duration of EVD; time of imaging following removal; hemorrhage on imaging following removal; and any other related complications during hospitalization.
technique of evd placement
The majority of ventriculostomies were performed in the frontal region, using a standard technique. The patient is placed supine, and the entry point is identified just anterior to the coronal suture in the midpupillary plane. The area is shaved, prepared, and draped in a sterile fashion, and the planned incision is infiltrated with local anesthetic. A small opening is made in the skull with a twist drill, and the dura is punctured with a spinal needle. An antibiotic-impregnated ventricular catheter (Bactiseal, DePuy Synthes) is advanced over a stylet perpendicular to the brain, and the frontal horn of the lateral ventricle is cannulated. The catheter is then tunneled subcutaneously out a separate stab incision approximately 5 cm away from the insertion site, secured to the scalp, and connected to a closed drainage system. An occipital approach was used for some patients. The insertion technique is similar, except that the patients are placed prone, with the entry point made 6 cm above the external occipital protuberance and 3 cm lateral to midline. The trajectory for the catheter is toward the ipsilateral medial canthus, and the catheter is inserted to a length up to 12 cm.
determination of evd-related hemorrhage
One author reviewed all imaging studies obtained during the index hospitalization for hemorrhage and compared findings to official radiology reports. Any imaging from the time of placement or removal to 3 days after was examined for hemorrhage to ensure that slowly forming hemorrhages were not missed. A hemorrhage related to EVD placement was defined as any new hemorrhage along the ventricular catheter tract noted on postprocedural imaging that was not present on preprocedural imaging. Hemorrhage related to EVD removal was described as any new hemorrhage noted along the prior catheter tract or within the ventricles after removal. This definition required that the post-EVD removal imaging was compared with an imaging study obtained following EVD insertion. The size and volume of each hemorrhage was calculated by measuring the maximal dimensions in the X (A), Y (B), and Z (C) axes and using the formula A×B×C/2. 16 Medical records were reviewed to determine the clinical significance of the hemorrhage. We defined a hemorrhage to be clinically significant if the patient exhibited a temporally related deterioration in neurological examination. There was some difficultly in determining clinical significance of the hemorrhage if other processes confounded the patient's neurological condition.
statistical analysis
To compare groups, a 2-sample t-test was used for continuous variables (age, duration of EVD), and a chi-square test or Fisher's exact test was used for categorical variables (comorbidities, location). Logistic regression analysis was performed to examine potential risk factors for hemorrhage on EVD placement and EVD removal. The method of generalized estimating equations was used to account for within-patient correlations since some patients had multiple EVDs. Backward selection was conducted to select the strongest set of risk factors using statistical analysis software (version 9.3, SAS Institute Inc.). A 2-sided p value < 0.05 was considered statistically significant.
results
From March 2008 to June 2014, 482 EVDs were placed in 380 patients (Table 2) . Four hundred nine EVDs were placed in adult patients (age 18-81 years), and 73 were placed in pediatric patients (age 2 weeks-17 years). The majority of the EVDs were placed in the frontal region (457), followed by the occipital (14) , parietal (8) , and temporal regions (3). Fifty-five percent of the procedures (267) were performed at bedside, with the remainder (215) placed in the operating room. Frameless stereotactic image guidance was used in 54 ventriculostomies, ultrasound guidance for 25, and endoscopy for 13. Table 3 displays the indications for EVDs, the most frequent of which was hemorrhage (213).
The length of time for which an EVD was necessary varied from 1 to 38 days (mean [± SD] 8.56 ± 6.17 days). Seventy-six EVDs (15.8%) were eventually converted to permanent CSF shunts. The mean length of time during which the EVD was in place in this group was 12.0 ± 7.52 days. Care was withdrawn in 87 patients (22.9%) while the EVD was in place.
One hundred sixteen EVDs were placed in patients who had been on anticoagulants or antiplatelet agents upon presentation to the hospital. Forty-six EVDs were placed in patients with underlying systemic coagulopathies due to liver disease, end stage renal disease, lymphoproliferative disorders, and chemotherapy, while 25 were placed in patients with both prior anticoagulant/antiplatelet and a systemic coagulopathy. Anticoagulation or antiplatelet therapy was initiated prior to EVD removal in 148 cases.
hemorrhage associated with placement
Imaging was obtained after 435 EVD placements, and 94 hemorrhages (21.6%) were identified ( Fig. 1) . Three hundred forty-one EVDs were not associated with a hemorrhage, while no imaging was obtained after 47 EVD placements. The hemorrhage volume ranged from 0.003 cm 3 to 45.9 cm 3 (mean 1.96 ± 6.48 cm 3 ). The vast majority of these hemorrhages (83) were intracerebral, in addition to 1 intraventricular hemorrhage, 3 epidural hematomas, 2 subdural hematomas, and 5 events that were a combi- ), and 1 patient required the placement of a contralateral EVD. Two patients with hemorrhage had withdrawal of care shortly after EVD placement given their poor prognosis from their underlying disease.
Univariate analysis was performed on all recorded parameters in patients with hemorrhage following EVD placement, and several parameters were found to be statistically significant: international normalized ratio (INR) at admission, admission platelet count, pre-EVD platelet count, number of placement attempts, presence of liver or renal disease, transfusion prior to placement, and setting for placement (Table 4 ). After backward model selection, we found that only admission platelet count and the number of attempts at placement were associated with hemorrhage on EVD placement (odds ratio [OR], 95% CI 0.99-0.99, p = 0.01; OR 3.06, 95% CI 1.81-5.18, p < 0.01, respectively). For an admission platelet count increase of 1000, we expect to see a 0.3% decrease in the odds of hemorrhage on EVD placement. For each additional attempt, we expect to see a 306% increase in the odds of hemorrhage on EVD placement.
hemorrhage associated with evd removal
Fifty-five new hemorrhages (22.5%) were noted after 244 EVD removals in patients in whom imaging was obtained after the EVD was removed (Fig. 2) ). Intracerebral hemorrhages, again, accounted for the majority of the hemorrhages (46), as well as intraventricular hemorrhage in 6 patients and a combination of hemorrhages in 3 patients. No patients required surgical evacuation; however, 2 patients needed EVD replacement. One patient died due to a large intracerebral hemorrhage after EVD removal (hemorrhage volume 82.08 cm 3 ). Eighteen patients had hemorrhage on both EVD placement and removal.
The only parameter found to be statistically significant on univariate analysis for hemorrhage following EVD removal was the use of image guidance (Table 5) . Multivariate analysis was completed with only the physical location for EVD placement (bedside vs operating room) being associated with hemorrhage (OR 1.00, 95% CI 1.00-1.00, reference p value; OR 0.47, 95% CI 0.26-0.85, p = 0.01, respectively). We found that the odds of a hemorrhage occurring on EVD removal were 53% lower for placement procedures carried out in the operating room than for those performed at the bedside.
discussion
Ventriculostomy is one of the most common neurosurgical procedures and is the mainstay of management for many neurosurgical conditions. The most common complications of ventriculostomy are infection and hemorrhage. A review of 13 studies from 1970 to 2008, comprising 1790 EVDs, found the incidence of hemorrhage associated with placement to be 5.7%. 4 A meta-analysis of 16 studies over the same period involving 2428 EVDs reported an incidence of 7.0%. 3 The recent literature on hemorrhage related to EVD placement has shown that it is more prevalent than previously reported. 8, 11, 15, 20, 33 This may be due to standard imaging protocols, which have become more routine in contemporary practice, and advancements in imaging, allowing the detection of very small hemorrhages.
Numerous articles have reported hemorrhage associated with EVD placement, and several have identified related risk factors. In a study investigating the use of tissue plasminogen activator in patients with intraventricular hemorrhage, there was an increased risk of hemorrhage if the EVD had been incorrectly placed. 12 A separate study showed patients over the age of 75 years who presented with intracerebral hemorrhage had an increased incidence of hemorrhage related to EVD placement. 33 Another report claimed that admission diagnosis of cerebrovascular disease increased the incidence of EVD placement hemorrhage. 20 The presence of antiplatelet exposure prior to EVD placement in studies has also been associated with increased hemorrhage rates. 15, 18 Two studies have also reported a trend toward increased rates of hemorrhage with EVDs placed while patients were in the intensive care unit compared with those placed while patients were in an operating room. 6, 8 In our study population, the incidence of hemorrhage on EVD placement was 21.6% in all patients who underwent postventriculostomy imaging. The vast majority of these hemorrhages were small (87 of 94 were less than 5 cm 3 ), and only 1 patient required surgical intervention. To our surprise, we did not find an association between the use of antiplatelet agents and increased risk of hemorrhage following EVD placement, as has been reported in previous studies. However, we did find that a decreased platelet count on admission was associated with hemorrhage following placement. We found only 1 other study that included admission platelets in its analysis, but no correlation was found between this variable and hemorrhage. 33 In our population, an increasing number of attempts for EVD placement was also found to have an increased risk of hemorrhage. This differs from a study reviewing multiple passes during EVD placement, in which no connection was identified between the number of passes and incidence of hemorrhage. 25 To our knowledge, hemorrhage following removal of EVD has only been cited in 3 articles. These studies reported the incidence, which ranged from 1.1% to 6.9%, but did not explore the possible causative factors. In the present study, we found an incidence of 22.5%, although it is important to note that only half of our patients underwent imaging after EVD removal. It is possible that the incidence may be higher with additional small asymptomatic hemorrhages not being identified. Several parameters were evaluated in this study to determine their relationship to hemorrhage on EVD removal. We found that only the bedside placement was associated with an increase in EVD removal hemorrhage. This correlation may be incidental as we did not study the relationship between location of the procedure and the number of attempts. Unexpectedly, the INR value prior to placement and removal was not related to hemorrhage risk. This finding has also been found in trauma patients, where supratherapeutic INRs (> 1.2) were not associated with an increased risk of EVD hemorrhage. 2, 5 While the mechanism of hemorrhage on EVD placement is understood, the exact etiology for hemorrhage on EVD removal is unclear. There are several potential causes for these hemorrhages. In patients with intraventricular hemorrhage, pulling of the EVD may draw some of this blood along the catheter tract. In a similar manner, it is possible that scalp bleeding may track along the course of the catheter. The catheter itself may injure and tamponade a small vessel during insertion, or its radio-opacity may obscure a small hemorrhage until it is removed. The catheter can become adherent to the choroid plexus or surrounding parenchyma that may hemorrhage on removal. Direct trauma to the parenchyma from EVD withdrawal is possible, although removals are performed without a rigid inner stylet. The removal of EVDs is often viewed as a benign procedure, and many clinicians may have less stringent requirements for coagulation parameters and the use of anticoagulants or antiplatelet agents, which could lead to these hemorrhages.
The majority of the hemorrhages found in this study were small and asymptomatic (Fig. 3) . Small hemorrhages of less than 10 cm 3 usually do not cause mass effect, as we found with 89 of 94 placement hemorrhages and 47 of 54 removal hemorrhages. Large hemorrhages (> 30 cm 3 ) only occurred in 2 of 94 placement hemorrhages and 5 of 54 removal hemorrhages, with 1 hemorrhage necessitating an EVD, 1 requiring surgical evacuation, and 1 leading to withdrawal of care. Interestingly, 3 of the large hemorrhages noted with EVD removal were entirely intraventricular. Regardless of the size of the hemorrhage, there can be associated clinical consequences, such as potential seizure focus, parenchymal damage, and neurocognitive changes. EVD-related hemorrhages can also affect a patient's recovery, length of hospitalization stay, and may require additional procedures. A large hemorrhage after EVD removal resulted in the death of 1 of our patients. Despite the small size of many of these hemorrhages, it is important to recognize the potential serious complications associated with this procedure.
This analysis is a retrospective, single institution study with several limitations. We maintain a database specifically for EVD placement, and the data are entered by the operators following each procedure. A procedure note is also written in the electronic medical record after every procedure, which includes the number of attempts. Consequently, there may be underreporting of the number of attempts needed for each EVD placement. There is no uniform protocol for obtaining routine imaging after EVD placement or removal, and the decision to do so is often left to the neurosurgeon's discretion. It is possible that some hemorrhages were missed in patients who did not undergo imaging. If so, these hemorrhages were of small volume, as clinically significant hemorrhages often lead to neurological changes prompting further imaging. The underlying neurological disease that necessitates an EVD often obscures the examination, making it difficult to determine whether a hemorrhage is asymptomatic or clinically significant. Given that many of our patients had a substantial degree of neurological dysfunction, it is possible that any new deficits related to the EVD placement or removal were not detected.
A significant potential confounder for this study is the possibility that radio-opaque catheters may obscure small hemorrhages associated with placement, and that these hemorrhages may not be identified until the catheter is removed. Without performing the study with radiolucent catheters, which are not available at our institution, it is impossible to identify these hemorrhages. Of the 55 hemorrhages recorded after EVD removal, 34 of these hemorrhages had volumes less than 1.0 cm 3 , a volume that has the possibility of being obscured by a catheter. The imaging for this subset of patients was reviewed a second time. Based on the volume and location, 24 of these hemorrhages could have been obscured by the catheter while 10 of the hemorrhages would have been evident with the catheter in place.
conclusions
Multiple studies have investigated hemorrhage related to EVD placement, with rates varying from 0% to 42%, while very few studies have described hemorrhage secondary to EVD removal. This is the first reported analysis of risk factors associated with hemorrhage on EVD removal. In this series of patients, decreased platelet count on admission and an increasing number of attempts for 
